219 related articles for article (PubMed ID: 11734621)
41. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis.
Taylor AH; Guzail M; Al-Azzawi F
Br J Dermatol; 2008 Feb; 158(2):319-28. PubMed ID: 18076706
[TBL] [Abstract][Full Text] [Related]
43. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
[TBL] [Abstract][Full Text] [Related]
44. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
[TBL] [Abstract][Full Text] [Related]
45. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM
Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836
[TBL] [Abstract][Full Text] [Related]
46. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
47. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
48. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
Monroe DG; Getz BJ; Johnsen SA; Riggs BL; Khosla S; Spelsberg TC
J Cell Biochem; 2003 Oct; 90(2):315-26. PubMed ID: 14505348
[TBL] [Abstract][Full Text] [Related]
49. Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions.
Shoker BS; Jarvis C; Davies MP; Iqbal M; Sibson DR; Sloane JP
Br J Cancer; 2001 Apr; 84(8):1064-9. PubMed ID: 11308255
[TBL] [Abstract][Full Text] [Related]
50. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer.
Fujimura T; Takahashi S; Urano T; Ogawa S; Ouchi Y; Kitamura T; Muramatsu M; Inoue S
Biochem Biophys Res Commun; 2001 Dec; 289(3):692-9. PubMed ID: 11726203
[TBL] [Abstract][Full Text] [Related]
51. Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.
Fuqua SA; Schiff R; Parra I; Moore JT; Mohsin SK; Osborne CK; Clark GM; Allred DC
Cancer Res; 2003 May; 63(10):2434-9. PubMed ID: 12750263
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling?
Skliris GP; Carder PJ; Lansdown MR; Speirs V
Br J Cancer; 2001 Apr; 84(8):1095-8. PubMed ID: 11308260
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.
Huang B; Omoto Y; Iwase H; Yamashita H; Toyama T; Coombes RC; Filipovic A; Warner M; Gustafsson JÅ
Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1933-8. PubMed ID: 24449868
[TBL] [Abstract][Full Text] [Related]
54. Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk.
Magri F; Capelli V; Rotondi M; Leporati P; La Manna L; Ruggiero R; Malovini A; Bellazzi R; Villani L; Chiovato L
Endocr Relat Cancer; 2012 Aug; 19(4):463-71. PubMed ID: 22531679
[TBL] [Abstract][Full Text] [Related]
55. [Immunohistochemical study of breast neoplasms cells using different markers of proliferation].
Uporov AV; Semiglazov VF; Pozharisskiĭ KM
Arkh Patol; 2000; 62(2):26-30. PubMed ID: 10789010
[TBL] [Abstract][Full Text] [Related]
56. Estrogen receptor beta in breast cancer.
Palmieri C; Cheng GJ; Saji S; Zelada-Hedman M; Wärri A; Weihua Z; Van Noorden S; Wahlstrom T; Coombes RC; Warner M; Gustafsson JA
Endocr Relat Cancer; 2002 Mar; 9(1):1-13. PubMed ID: 11914179
[TBL] [Abstract][Full Text] [Related]
57. Messenger ribonucleic acid in situ hybridization analysis of estrogen receptors alpha and beta in human breast carcinoma.
Sasano H; Suzuki T; Matsuzaki Y; Fukaya T; Endoh M; Nagura H; Kimura M
J Clin Endocrinol Metab; 1999 Feb; 84(2):781-5. PubMed ID: 10022453
[TBL] [Abstract][Full Text] [Related]
58. Estrogen receptor beta in breast cancer: associations between ERbeta, hormonal receptors, and other prognostic biomarkers.
Choi Y; Pinto M
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):19-24. PubMed ID: 15722789
[TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer.
Gustafsson JA; Warner M
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):245-8. PubMed ID: 11162931
[TBL] [Abstract][Full Text] [Related]
60. [Immunomorphological characteristics of primary and recurrent breast neoplasms].
Volchenko NN; Zavalishina LE; Shimbireva IB; Frank GA
Arkh Patol; 1998; 60(4):4-7. PubMed ID: 9791688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
